Raptor Pharmaceutical Corp. (RPTP)-Financial and Strategic SWOT Analysis Review

Raptor Pharmaceutical Corp. (RPTP)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH82575FSA
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Raptor Pharmaceuticals Corp. (Raptor) is a biopharmaceutical company that develops and commercializes therapeutics for orphan diseases. The company's lead product, Procysbi is a cysteamine bitartrate delayed-release capsule and is used in the treatment of a rare genetic disorder, nephropathic cystinosis. Its second product, Quinsair finds application in treating chronic pulmonary infections due to Pseudomonas aeruginosa in adults with cystic fibrosis. Raptor's clinical stage product candidates include RP103, non-alcoholic fatty liver disease, and Convivia. The company offers preclinical programs such as HepTide, for the treatment of primary liver cancer; and ADO (cysteamine dioxygenase), for the treatment of diseases for which cysteamine is a medicine. Raptor is headquartered in Novato, California, the US.

Raptor Pharmaceutical Corp. Key Recent Developments

Aug 04, 2016: Raptor Pharmaceutical Reports Second Quarter 2016 Financial Results

May 05, 2016: Raptor Pharmaceutical Reports First Quarter 2016 Financial Results

Feb 25, 2016: Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Corporate Update

Nov 05, 2015: Raptor Pharmaceutical Reports Third Quarter 2015 Financial Results and Provides Corporate Update

Aug 06, 2015: Raptor Pharmaceutical Reports Second Quarter 2015 Financial Results and Provides Corporate Update

This comprehensive SWOT profile of Raptor Pharmaceutical Corp. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Raptor Pharmaceutical Corp. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Section 1-About the Company

Raptor Pharmaceutical Corp.-Key Information

Raptor Pharmaceutical Corp.-Overview

Raptor Pharmaceutical Corp.-Key Employees

Raptor Pharmaceutical Corp.-Key Employee Biographies

Raptor Pharmaceutical Corp.-Key Operational Heads

Raptor Pharmaceutical Corp.-Major Products and Services

Raptor Pharmaceutical Corp.-History

Raptor Pharmaceutical Corp.-Company Statement

Raptor Pharmaceutical Corp.-Locations And Subsidiaries

Raptor Pharmaceutical Corp.-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Raptor Pharmaceutical Corp.-Business Description

Raptor Pharmaceutical Corp.-Corporate Strategy

Raptor Pharmaceutical Corp.-SWOT Analysis

SWOT Analysis-Overview

Raptor Pharmaceutical Corp.-Strengths

Raptor Pharmaceutical Corp.-Weaknesses

Raptor Pharmaceutical Corp.-Opportunities

Raptor Pharmaceutical Corp.-Threats

Raptor Pharmaceutical Corp.-Key Competitors

Section 3-Company Financial Performance Charts

Raptor Pharmaceutical Corp.-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List of Figures

Raptor Pharmaceutical Corp., Performance Chart

Raptor Pharmaceutical Corp., Ratio Charts

List of Tables

Raptor Pharmaceutical Corp., Key Information

Raptor Pharmaceutical Corp., Key Ratios

Raptor Pharmaceutical Corp., Share Data

Raptor Pharmaceutical Corp., Major Products and Services

Raptor Pharmaceutical Corp., History

Raptor Pharmaceutical Corp., Key Employees

Raptor Pharmaceutical Corp., Key Employee Biographies

Raptor Pharmaceutical Corp., Key Operational Heads

Raptor Pharmaceutical Corp., Other Locations

Raptor Pharmaceutical Corp., Subsidiaries

Raptor Pharmaceutical Corp., Key Manufacturing facilities

Raptor Pharmaceutical Corp., Key Competitors

Raptor Pharmaceutical Corp., SWOT Analysis

Raptor Pharmaceutical Corp., Ratios based on current share price

Raptor Pharmaceutical Corp., Annual Ratios

Raptor Pharmaceutical Corp., Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Raptor Pharmaceutical Corp., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 20517
Site License
USD 600 INR 41034
Corporate User License
USD 900 INR 61551



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com